Phage M13 for the treatment of Alzheimer and Parkinson disease

Joachim Messing1

  • 1Waksman Institute of Microbiology, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.

Gene
|February 13, 2016
PubMed

Insights

Microbial studies, especially bacteriophages like M13, offer new insights into basic biology. Recent discoveries show M13 phage properties may provide a novel strategy for treating neurodegenerative diseases.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Neuroscience

Background:

  • Microbial studies have advanced understanding of infectious diseases and fundamental biological processes.
  • Bacteriophages, or bacterial viruses, are valuable tools for studying cellular mechanisms due to easily isolatable components.
  • Filamentous phage M13 has been a subject of extensive research in molecular biology.

Purpose of the Study:

  • To review recent discoveries regarding the filamentous phage M13.
  • To explore the potential of M13 phage properties as a novel therapeutic approach for neurodegenerative diseases.

Main Methods:

  • Review of existing scientific literature on M13 phage biology and neurodegenerative disease research.
  • Analysis of M13 phage characteristics relevant to biological mechanisms.

Main Results:

  • Identification of specific properties of M13 phage.
  • Emerging evidence suggesting M13 phage's potential utility in combating neurodegenerative conditions.

Conclusions:

  • The unique characteristics of M13 phage present a promising avenue for developing new treatments for neurodegenerative diseases.
  • Further research is warranted to fully elucidate and harness the therapeutic potential of M13 phage in this context.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.4K